Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

FORTIS HEALTHCARE 2023-24 Annual Report Analysis
Tue, 16 Jul

FORTIS HEALTHCARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

FORTIS HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 9.5% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 8.1% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 18.8% in FY24 as against 19.0% in FY23.
  • Depreciation charges increased by 8.5% and finance costs increased by 1.4% YoY, respectively.
  • Other income declined by 38.0% YoY.
  • Net profit for the year grew by 1.9% YoY.
  • Net profit margins during the year declined from 10.1% in FY23 to 9.4% in FY24.

FORTIS HEALTHCARE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 62,976 68,929 9.5%
Other income Rs m 617 383 -38.0%
Total Revenues Rs m 63,593 69,312 9.0%
Gross profit Rs m 11,968 12,932 8.1%
Depreciation Rs m 3,157 3,425 8.5%
Interest Rs m 1,291 1,309 1.4%
Profit before tax Rs m 8,137 8,580 5.4%
Tax Rs m 1,807 2,127 17.7%
Profit after tax Rs m 6,330 6,452 1.9%
Gross profit margin % 19.0 18.8
Effective tax rate % 22.2 24.8
Net profit margin % 10.1 9.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

FORTIS HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 32 billion as compared to Rs 13 billion in FY23, thereby witnessing an increase of 141.3%.
  • Long-term debt stood at Rs 7 billion as compared to Rs 6 billion during FY23, a growth of 29.5%.
  • Current assets rose 23% and stood at Rs 14 billion, while fixed assets rose 8% and stood at Rs 116 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 130 billion as against Rs 121 billion during FY23, thereby witnessing a growth of 7%.

FORTIS HEALTHCARE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 72,405 76,611 5.8
 
Current Liabilities Rs m 13,136 31,702 141.3
Long-term Debt Rs m 5,722 7,409 29.5
Total Liabilities Rs m 120,893 129,714 7.3
 
Current assets Rs m 11,503 14,202 23.5
Fixed Assets Rs m 106,830 115,508 8.1
Total Assets Rs m 120,893 129,714 7.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



FORTIS HEALTHCARE Cash Flow Statement Analysis

  • FORTIS HEALTHCARE's cash flow from operating activities (CFO) during FY24 stood at Rs 11 billion, an improvement of 33.8% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -9 billion, an improvement of 137.2% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -865 million, an improvement of 82% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs 1 billion from the Rs -215 million net cash flows seen during FY23.

FORTIS HEALTHCARE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 8,222 11,001 33.8%
Cash Flow from Investing Activities Rs m -3,737 -8,864 -
Cash Flow from Financing Activities Rs m -4,712 -865 -
Net Cash Flow Rs m -215 1,245 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for FORTIS HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 8.5, an improvement from the EPS of Rs 8.4 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 488.8, stands at 58.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 4.8 times, while the price to sales ratio stands at 5.4 times.
  • The company's price to cash flow (P/CF) ratio stood at 27.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 83.4 91.3
TTM Earnings per share Rs 8.4 8.5
Diluted earnings per share Rs 8.4 8.5
Price to Cash Flow x 20.7 27.5
TTM P/E ratio x 32.1 58.0
Price / Book Value ratio x 2.8 3.6
Market Cap Rs m 205,575 272,068
Dividends per share (Unadj.) Rs 1.0 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for FORTIS HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 0.4x during FY24, from 0.9x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 7.6x during FY24, from 7.3x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 8.4% during FY24, from 8.7% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 11.8% during FY24, from 12.1% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 6.0% during FY24, from 6.3% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 0.9 0.4
Debtors’ Days Days 337 332
Interest coverage x 7.3 7.6
Debt to equity ratio x 0.1 0.1
Return on assets % 6.3 6.0
Return on equity % 8.7 8.4
Return on capital employed % 12.1 11.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how FORTIS HEALTHCARE has performed over the last 5 years, please visit here.

FORTIS HEALTHCARE Share Price Performance

Over the last one year, FORTIS HEALTHCARE share price has moved up from Rs 326.7 to Rs 488.8, registering a gain of Rs 162.1 or around 49.6%.

Overall, the S&P BSE SENSEX is up 23.5% over the year.

(To know more, check out historical annual results for FORTIS HEALTHCARE and quarterly results for FORTIS HEALTHCARE)

Annual Report FAQs

What is the current share price of FORTIS HEALTHCARE?

FORTIS HEALTHCARE currently trades at Rs 680.6 per share. You can check out the latest share price performance of FORTIS HEALTHCARE here...

What was the revenue of FORTIS HEALTHCARE in FY24? How does it compare to earlier years?

The revenues of FORTIS HEALTHCARE stood at Rs 69,312 m in FY24, which was up 9.0% compared to Rs 63,593 m reported in FY23.

FORTIS HEALTHCARE's revenue has grown from Rs 46,850 m in FY20 to Rs 69,312 m in FY24.

Over the past 5 years, the revenue of FORTIS HEALTHCARE has grown at a CAGR of 10.3%.

What was the net profit of FORTIS HEALTHCARE in FY24? How does it compare to earlier years?

The net profit of FORTIS HEALTHCARE stood at Rs 6,452 m in FY24, which was up 1.9% compared to Rs 6,330 m reported in FY23.

This compares to a net profit of Rs 7,899 m in FY22 and a net loss of Rs -562 m in FY21.

Over the past 5 years, FORTIS HEALTHCARE net profit has grown at a CAGR of 63.0%.

What does the cash flow statement of FORTIS HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of FORTIS HEALTHCARE reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 11,001 m as compared to Rs 8,222 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -8,864 m as compared to Rs -3,737 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -865 m as compared to Rs -4,712 m in FY23.

Here's the cash flow statement of FORTIS HEALTHCARE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations1,7154,8558,6548,22211,001
From Investments604-1,351-5,144-3,737-8,864
From Financial Activity-8,616-1,429-5,173-4,712-865
Net Cashflow-6,2662,120-1,525-2151,245

What does the Key Ratio analysis of FORTIS HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of FORTIS HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and stood at 18.8% in FY24 as against 19.0% in FY23.
  • Net profit margins declined from 10.1% in FY23 to 9.4% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.1 as compared to 0.1 in FY23.

Here's the ratio/financial analysis of FORTIS HEALTHCARE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)14.811.224.619.018.8
Net Profit Margin (%)2.0-1.413.810.19.4
Debt to Equity Ratio (x)0.10.20.10.10.1

Equitymaster requests your view! Post a comment on "FORTIS HEALTHCARE 2023-24 Annual Report Analysis". Click here!